Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 28, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, Bristol-Myers Squibb, China, GSK, Novartis, Takeda, brexit

This week was diverse as always in terms of news coming out of the pharma industry, but the biggest news …
News
shutterstock_158366573

Healthcare communications: Time to think differently with patient centricity

June 27, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Spink, patient centricity, pharma

Patient centricity, derived from the NHS-driven thinking “no decision about me, without me”, has been adopted by pharma to understand …
Feature
512px-hpv_causing_cervical_cancer

Major review points to success of HPV vaccine, cervical cancer could be eradicated in developed nations

June 27, 2019 Research and Development Cancer, HPV, UK, cervical cancer, human papilloma virus, pharma, vaccines

A major new review published in The Lancet has supported the effectiveness of the human papilloma virus (HPV) vaccine in …
News
astrazeneca-sign

AstraZeneca’s Imfinzi meets endpoint at Phase 3 interim analysis in extensive-stage small cell lung cancer

June 27, 2019 Research and Development AstraZeneca, Imfinzi, pharma

AstraZeneca has lifted the curtain on new Phase 3 data for Imfinzi (durvalumab) in the first-line treatment of extensive-stage small …
News
antibiotic_sensitvity_and_resistance

Rare Group A strep outbreak kills 12 and infects 20 in Essex

June 26, 2019 Medical Communications, Research and Development England, NHS, UK, outbreak, pharma

An outbreak of the rare contagious bacteria Group A streptococcal (iGAS) infection in Essex, UK, has resulted in 32 cases …
News
novartis_side_building

Novartis provides promising update on Cosentyx in plaque psoriasis

June 26, 2019 Research and Development Cosentyx, Novartis, pharma, psoriasis

Novartis has revealed brief new data on its IL-17A antibody Cosentyx (secukinumab) in the treatment off plaque psoriasis, showing that …
News
acer_therapeutics

Acer’s shares drop 80% as FDA rejects drug for vascular Ehlers-Danlos syndrome

June 26, 2019 Research and Development, Sales and Marketing Acer Therapeutics, Edsivo, pharma

Acer Therapeutics has seen its share value plunge by 80% after it emerged that the FDA had turned down its …
News
shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019 Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …
News

China urges firms to make generic versions of 34 drugs

June 25, 2019 Research and Development China, NHC, generic drugs, generics, patents, pharma

China’s National Health Commission (NHC) has urged generic drugmakers to pick up the production of 34 drugs that are not …
News
w36

FREE WEBINAR: Virtually engaged or engaged virtually?

June 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, Within3, pharma

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …
News
brexit

The Brexit ‘cliff edge’: How life sciences can survive

June 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …
Feature
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 21, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, MSD, Parkinson's, blockchain, brexit, top ten

It’s Friday, and time for another run-down of the week’s most popular articles.
News
shutterstock_114045100

Sanofi to axe 466 R&D positions in Germany and France

June 21, 2019 Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …
News
800px-blausen_0704_parkinsonsdisease

Scientists at King’s College London identify early signs of Parkinson’s disease

June 20, 2019 Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin

Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 …
News
gilead-sciences

Gilead signs deal with Nurix Therapeutics worth more than $2.3 billion

June 20, 2019 Business Services, Research and Development Gilead, Nurix Therapeutics, pharma, protiens

Gilead has signed a deal with San Francisco biotech Nurix Therapeutics – a company focused on developing drugs that control …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025